| Name | Title | Contact Details |
|---|
Condensed Curriculum International Inc is a Fairfield, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Professional Compounding Centers of America is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Topcon Medical Systems (TMS), based in Oakland, NJ, is a leading developer and supplier of diagnostic equipment for the ophthalmic community. Topcon`s mission is to make impossible ideas possible, by constantly developing new optical and measurement technologies. Our goal is simple: to provide you with the most innovative equipment so that you can better serve your patients. For over 35 years, TMS has been leading the way with the most technically advanced instrumentation in the marketplace. Our product line comprises the largest selection of precision instruments from one manufacturer . . . providing products for a wide range of applications, including imaging, diagnostic, refractive, lens processing, surgical, and delivery. Whatever your particular instrument requirements, Topcon has the innovative solution you need. All of our products are developed with the practitioner`s needs in mind and backed up by a network of dedicated service specialists. The Topcon name carries a reputation of utmost integrity and products of the highest quality. As a testament to this, we were recently awarded the ISO 9001-2000 Certification, an international quality management and assurance system that applies to facilities that design, develop, manufacture, install, and service products. Topcon Medical Systems is a wholly owned subsidiary of Topcon Corporation of Tokyo, Japan.
Intrexon Corporation (NYSE: XON) is a leader in synthetic biology focused on collaborating with companies in Health, Food, Energy, Environment, and Consumer Sectors to create biologically-based products that improve the quality of life and the health of the planet. Through the company’s proprietary UltraVector® platform and and suite of technologies, Intrexon provides its partners with industrial-scale design and development of complex biological systems. The UltraVector® platform delivers unprecedented control over the quality, function, and performance of living cells. We call our synthetic biology approach and integrated technologies Better DNA®, and we invite you to discover more at www.DNA.com.
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.